Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Santhera nominiert Ex-Idorsia-Chefin Srishti Gupta als Verwaltungsratsmitglied (Cash) +++ SANTHERA Aktie -4,41%

IMCD Aktie

 >IMCD Aktienkurs 
110 EUR    +13.6%    (TradegateBSX)
Ask: 110 EUR / 50 Stück
Bid: 104 EUR / 50 Stück
Tagesumsatz: 805 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
IMCD Aktie über LYNX handeln
>IMCD Performance
1 Woche: +1,0%
1 Monat: +14,7%
3 Monate: +23,9%
6 Monate: +7,7%
1 Jahr: -16,9%
laufendes Jahr: +26,1%
>IMCD Aktie
Name:  IMCD N.V. EO -,16
Land:  Niederlande
Sektor:  Chemie
ISIN/ Wkn:  NL0010801007 / A116P8
Symbol/ Ticker:  INX (Frankfurt)
Kürzel:  FRA:INX, ETR:INX, INX:GR
Index:  AEX
Webseite:  https://www.imcdgroup.com..
Profil:  IMCD N.V. is a global leader in the distribution and formulation of specialty chemicals and ingredients. Founded in 1995 in Rotterdam, Netherlands, by a group of companies under the leadership of Piet van der Slikke, it emerged from Internatio-Mülle..
>Volltext..
Marktkapitalisierung:  5792.41 Mio. EUR
Unternehmenswert:  7309.9 Mio. EUR
Umsatz:  4792.4 Mio. EUR
EBITDA:  537.09 Mio. EUR
Nettogewinn:  218.19 Mio. EUR
Gewinn je Aktie:  3.69 EUR
Schulden:  1758.72 Mio. EUR
Liquide Mittel:  239.26 Mio. EUR
Operativer Cashflow:  323.19 Mio. EUR
Bargeldquote:  0.23
Umsatzwachstum:  1.08%
Gewinnwachstum:  -21.8%
Dividende je Aktie:  -
Dividendenrendite:  2.19%
Dividendenschätzung:  1.84%
Div. Historie:  29.04.25 - 2.15€
16.05.24 - 2.24€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  IMCD
Letzte Datenerhebung:  30.04.26
>IMCD Kennzahlen
Aktien/ Unternehmen:
Aktien: 59.03 Mio. St.
Frei handelbar: 98.98%
Rückkaufquote: 0.13%
Mitarbeiter: 5246
Umsatz/Mitarb.: 0.91 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 12.41%
Bewertung:
KGV: 26.27
KGV lG: 17.92
KUV: 1.17
KBV: 2.79
PEG-Ratio: -
EV/EBITDA: 13.61
Rentabilität:
Bruttomarge: 10.18%
Gewinnmarge: 4.55%
Operative Marge: 8.22%
Managementeffizenz:
Gesamtkaprendite: 4.54%
Eigenkaprendite: 10.23%
 >IMCD Anleihen 
>IMCD Peer Group
Chemie, Spezialchemie, Lacke, Farben & Pigmente, Agrochemie
 
30.04.26 - 07:54
IMCD N.V. Q1 Profit Declines (AFX)
 
BRUSSELS (dpa-AFX) - IMCD N.V. (IMCD.AS) released earnings for first quarter that Dropped, from last yearThe company's earnings came in at EUR63 million, or EUR1.06 per share. This compares with E......
30.04.26 - 07:03
IMCD reports EBITA of EUR 130 million in the first three months of 2026 (GlobeNewswire EN)
 
Rotterdam, The Netherlands (30 April 2026) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its first three months 2026 results....
13.04.26 - 11:03
IMCD First Three Months 2026 results webcast invitation (GlobeNewswire EN)
 
Rotterdam, The Netherlands (13 April 2026) ...
19.03.26 - 08:03
IMCD publishes convocation for its upcoming AGM (GlobeNewswire EN)
 
Rotterdam, the Netherlands (19 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today published the convocation and agenda for its Annual General Meeting of Shareholders (AGM), which will be held on Thursday 30 April 2026 at 10:30 CEST at the Company's offices at Wilhelminaplein 32, 3072 DE Rotterdam, the Netherlands....
04.03.26 - 08:06
IMCD nominates Andreas Igerl as CCO and member of the Management Board (GlobeNewswire EN)
 
Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Andreas Igerl to become Chief Commercial Officer (CCO) and member of the Management Board....
04.03.26 - 08:06
IMCD releases 2025 Annual Report (GlobeNewswire EN)
 
Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today releases its 2025 Annual Report. The report offers the Company's stakeholders a comprehensive view of IMCD's performance in 2025....
04.03.26 - 08:06
IMCD nominates Ruud Joosten as Supervisory Board member (GlobeNewswire EN)
 
Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Ruud Joosten as member of the Supervisory Board....
20.02.26 - 08:03
IMCD to acquire Willows Ingredients to strengthen its food & nutrition offering throughout Ireland and the UK (GlobeNewswire EN)
 
Rotterdam, the Netherlands (20 February 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces it has signed an agreement to acquire 100% of the shares in Willows Ingredients Group Limited (Willows Ingredients), a distributor of ingredients serving the food and nutrition sector with expertise in health, sports and animal nutrition. The company predominantly serves customers across Ireland and the UK....
19.02.26 - 10:45
AKTIE IM FOKUS: Azelis erholt - Schwache Zahlen keine Überraschung nach IMCD (DPA-AFX)
 
FRANKFURT/AMSTERDAM (dpa-AFX) - Die Aktien von Azelis (Azelis Group) haben am Donnerstag trotz schwacher Geschäftszahlen mit zeitweise fast 10 Prozent Kurserholung ihren Einbruch vom Vortag wettgemacht....
18.02.26 - 16:42
IMCD N.V. GAAP EPS of EUR 5.19, revenue of EUR 4.8B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.02.26 - 12:21
AKTIE IM FOKUS: Chemikalienhändler IMCD sackt ab - Auch Brenntag schwach (DPA-AFX)
 
FRANKFURT/AMSTERDAM (dpa-AFX) - Die Aktien von IMCD sind am Mittwoch nach enttäuschenden Geschäftszahlen zeitweise um mehr als 15 Prozent eingebrochen. Damit näherten sich die Papiere des Chemikalienhändlers wieder ......
18.02.26 - 11:01
IMCD shares tumble 12% on earnings drop, dividend cut (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
18.02.26 - 11:00
IMCD Shares Plunge After Dividend Cut, Revenue Fall (WSJ EN)
 
Shares in the chemicals and food ingredients distributor were down 14%, after waning demand across its markets and regions stalled organic growth in 2025....
18.02.26 - 08:30
IMCD N.V. Full Year Income Declines (AFX)
 
BRUSSELS (dpa-AFX) - IMCD N.V. (IMCD.AS) released a profit for full year that Dropped, from last yearThe company's earnings totaled EUR217.58 million, or EUR3.68 per share. This compares with EUR2......
18.02.26 - 07:03
IMCD reports EBITA of EUR 498 million in 2025 (GlobeNewswire EN)
 
Rotterdam, The Netherlands (18 February 2026) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its full-year 2025 results....
21.01.26 - 10:15
IMCD Full Year results 2025 webcast invitation (GlobeNewswire EN)
 
Rotterdam, The Netherlands (21 January 2026) ...
12.12.25 - 11:12
IMCD regelt CFO-Nachfolge: Floris Lagerwerf übernimmt ab Januar 2027 (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.12.25 - 08:03
Floris Lagerwerf nominated future CFO of IMCD as of January 2027 (GlobeNewswire EN)
 
Rotterdam, The Netherlands (12 December 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Floris Lagerwerf to become Chief Financial Officer (CFO) of IMCD as of January 2027. Floris will succeed Hans Kooijmans, who has decided to retire as per the end of December 2026....
12.12.25 - 08:03
IMCD: Supervisory Board members nominated for reappointment (GlobeNewswire EN)
 
Rotterdam, The Netherlands (12 December 2025) – “IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces that the Supervisory Board of IMCD nominates Mr. Janus Smalbraak for reappointment as member and Chair of the Supervisory Board at the next Annual General Meeting (AGM) in 2026. In addition to the nomination of Janus Smalbraak, the Supervisory Board nominates Mr. Stephan Nanninga for a third term of two years and Mr. Willem Eelman for a second term of four years on the Supervisory Board of IMCD....
08.12.25 - 13:33
Recordati Rare Diseases Showcases Real-World Evidence Studies That Advance Understanding of Castleman Disease (CD) at the American Society of Hematology (ASH) Annual Meeting (PR Newswire)
 
Poster presentations highlight AI-driven CD histopathology grading technology; morbidity and financial burden of idiopathic multicentric CD (iMCD); severity of pediatric iMCD; and CD subtype classification BRIDGEWATER, N.J., Dec. 8, 2025 /PRNewswire/ -- Recordati Rare Diseases Inc. today......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Tiefe des menschlichen Herzens läßt sich nicht ausloten. - Sprichwort China
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!